rs538050088
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP3
The NM_018723.4(RBFOX1):c.1042C>A(p.Pro348Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,312 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P348S) has been classified as Uncertain significance.
Frequency
Consequence
NM_018723.4 missense
Scores
Clinical Significance
Conservation
Publications
- epilepsyInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- neurodevelopmental disorderInheritance: AD Classification: LIMITED Submitted by: G2P
- autism susceptibility 1Inheritance: Unknown Classification: LIMITED Submitted by: Laboratory for Molecular Medicine
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_018723.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RBFOX1 | NM_018723.4 | MANE Select | c.1042C>A | p.Pro348Thr | missense | Exon 15 of 16 | NP_061193.2 | ||
| RBFOX1 | NM_145893.3 | MANE Plus Clinical | c.1158C>A | p.Leu386Leu | synonymous | Exon 13 of 14 | NP_665900.1 | ||
| RBFOX1 | NM_001415888.1 | c.1558C>A | p.Pro520Thr | missense | Exon 17 of 18 | NP_001402817.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RBFOX1 | ENST00000550418.6 | TSL:1 MANE Select | c.1042C>A | p.Pro348Thr | missense | Exon 15 of 16 | ENSP00000450031.1 | ||
| RBFOX1 | ENST00000311745.9 | TSL:1 | c.1105C>A | p.Pro369Thr | missense | Exon 12 of 13 | ENSP00000309117.5 | ||
| RBFOX1 | ENST00000436368.6 | TSL:1 | c.1105C>A | p.Pro369Thr | missense | Exon 12 of 13 | ENSP00000402745.2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461312Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726930 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Idiopathic generalized epilepsy Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. This variant has not been reported in the literature in individuals affected with RBFOX1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces proline, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 369 of the RBFOX1 protein (p.Pro369Thr).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at